172 related articles for article (PubMed ID: 9723706)
1. Human B and T lymphocytes have similar amounts of CD21 mRNA, but differ in surface expression of the CD21 glycoprotein.
Braun M; Melchers I; Peter HH; Illges H
Int Immunol; 1998 Aug; 10(8):1197-202. PubMed ID: 9723706
[TBL] [Abstract][Full Text] [Related]
2. T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression.
Masilamani M; von Seydlitz E; Bastmeyer M; Illges H
Immunobiology; 2002 Dec; 206(5):528-36. PubMed ID: 12607728
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an Epstein-Barr virus receptor on human epithelial cells.
Birkenbach M; Tong X; Bradbury LE; Tedder TF; Kieff E
J Exp Med; 1992 Nov; 176(5):1405-14. PubMed ID: 1383386
[TBL] [Abstract][Full Text] [Related]
4. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes.
Illges H; Braun M; Peter HH; Melchers I
Clin Exp Immunol; 2000 Nov; 122(2):270-6. PubMed ID: 11091285
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells.
Henchoz-Lecoanet S; Jeannin P; Aubry JP; Graber P; Bradshaw CG; Pochon S; Bonnefoy JY
Immunology; 1996 May; 88(1):35-9. PubMed ID: 8707347
[TBL] [Abstract][Full Text] [Related]
7. Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21.
Larcher C; Kempkes B; Kremmer E; Prodinger WM; Pawlita M; Bornkamm GW; Dierich MP
Eur J Immunol; 1995 Jun; 25(6):1713-9. PubMed ID: 7614999
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the EBV/C3d receptor on the human Jurkat T cell line: evidence for a novel transcript.
Sinha SK; Todd SC; Hedrick JA; Speiser CL; Lambris JD; Tsoukas CD
J Immunol; 1993 Jun; 150(12):5311-20. PubMed ID: 8390533
[TBL] [Abstract][Full Text] [Related]
9. Allergen-induced CD23 on CD4+ T lymphocytes and CD21 on B lymphocytes in patients with allergic asthma: evidence and regulation.
Gagro A; Rabatić S
Eur J Immunol; 1994 May; 24(5):1109-14. PubMed ID: 7910139
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
June RA; Landay AL; Stefanik K; Lint TF; Spear GT
Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.
Fischer EM; Mouhoub A; Maillet F; Frémeaux-Bacchi V; Krief C; Gould H; Berrih-Aknin S; Kazatchkine MD
Int Immunol; 1999 Nov; 11(11):1841-9. PubMed ID: 10545488
[TBL] [Abstract][Full Text] [Related]
12. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.
Smith NA; Coleman CB; Gewurz BE; Rochford R
J Virol; 2020 May; 94(11):. PubMed ID: 32238579
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
[TBL] [Abstract][Full Text] [Related]
14. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
[TBL] [Abstract][Full Text] [Related]
15. CD21 is a ligand for CD23 and regulates IgE production.
Aubry JP; Pochon S; Graber P; Jansen KU; Bonnefoy JY
Nature; 1992 Aug; 358(6386):505-7. PubMed ID: 1386409
[TBL] [Abstract][Full Text] [Related]
16. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
Prodinger WM; Larcher C; Schwendinger M; Dierich MP
J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
[TBL] [Abstract][Full Text] [Related]
17. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE).
Levy E; Ambrus J; Kahl L; Molina H; Tung K; Holers VM
Clin Exp Immunol; 1992 Nov; 90(2):235-44. PubMed ID: 1424280
[TBL] [Abstract][Full Text] [Related]
19. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21).
Hannan JP
Curr Protein Pept Sci; 2016; 17(5):463-87. PubMed ID: 26916158
[TBL] [Abstract][Full Text] [Related]
20. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]